Page 354 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 354
Late Breaker ePosters (Cont.)
LP09 HIGH EFFICACY OF RETREATMENT WITH LEDPASVIR
AND SOFOSBUVIR IN HCV PATIENTS WHO FAILED INITIAL
SHORT COURSE THERAPY WITH COMBINATION DAA
REGIMENS (NIH SYNERGY TRIAL)
Eleanor M. P. Wilson*, Sarah Kattakuzhy, Zayani Sims, Lydia Tang,
Mary McLaughlin, Angie Price, Rachel Silk, Chloe Gross,
Elizabeth Akoth, Anu Osinusi, Henry Masur, Anita Kohli, Shyam Kottilil,
The United States
LP10 EFFICACY AND SAFETY OF VITAMIN E FOR
NONALCOHOLIC STEATOHEPATITIS: COMBINED
ANALYSIS OF THREE CONTROLLED TRIALS
Kris V. Kowdley*, Laura A. Wilson, Mark L. Van Natta, Rish K. Pai,
Arun J. Sanyal, The United States
LATE BREAKER ePOSTERS LP11 WARFARIN ANTICOAGULATION FOR LIVER FIBROSIS IN
PATIENTS TRANSPLANTED FOR HEPATITIS C (WAFT-C):
RESULTS AT ONE YEAR
Ameet Dhar*, Emmanuel Tschotazis, Rebecca Brown,
Pinelopi Manousou, Charles Millson, Mark Aldersley, Stuart Forbes,
Kosh Aggarwal, Amit Gera, Matthew Cramp, Andrew Holt,
David Mutimer, Stuart McPherson, Andrew Burroughs, Quentin Anstee,
Robert Goldin, Mark R. Thursz, The United Kingdom
LP12 SILYMARIN FOR THE TREATMENT OF NON-ALCOHOLIC
STEATOHEPATITIS: INTERIM ANALYSIS OF A
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED
TRIAL
Wah Kheong Chan*, Nik Raihan Nik Mustapha, Sanjiv Mahadeva,
Malaysia
LP13 EFFECT OF LONG TERM VIRAL SUPPRESSION WITH
SOFOSBUVIR + RIBAVIRIN ON HEPATIC VENOUS
PRESSURE GRADIENT IN HCV-INFECTED PATIENTS WITH
CIRRHOSIS AND PORTAL HYPERTENSION
Nezam Afdhal*, Gregory T. Everson, Jose Luis Calleja,
Geoffrey McCaughan, Jaime Bosch, Jill Denning, Diana M. Brainard,
John G. McHutchison, Theo Brandt-Sarif, Di An, Michael Charlton,
K. R. Reddy, Tarik Asselah, Edward Gane, Xavier Forns,
The United States
354 The International Liver Congress™ 2015 • ILC Programme
LP09 HIGH EFFICACY OF RETREATMENT WITH LEDPASVIR
AND SOFOSBUVIR IN HCV PATIENTS WHO FAILED INITIAL
SHORT COURSE THERAPY WITH COMBINATION DAA
REGIMENS (NIH SYNERGY TRIAL)
Eleanor M. P. Wilson*, Sarah Kattakuzhy, Zayani Sims, Lydia Tang,
Mary McLaughlin, Angie Price, Rachel Silk, Chloe Gross,
Elizabeth Akoth, Anu Osinusi, Henry Masur, Anita Kohli, Shyam Kottilil,
The United States
LP10 EFFICACY AND SAFETY OF VITAMIN E FOR
NONALCOHOLIC STEATOHEPATITIS: COMBINED
ANALYSIS OF THREE CONTROLLED TRIALS
Kris V. Kowdley*, Laura A. Wilson, Mark L. Van Natta, Rish K. Pai,
Arun J. Sanyal, The United States
LATE BREAKER ePOSTERS LP11 WARFARIN ANTICOAGULATION FOR LIVER FIBROSIS IN
PATIENTS TRANSPLANTED FOR HEPATITIS C (WAFT-C):
RESULTS AT ONE YEAR
Ameet Dhar*, Emmanuel Tschotazis, Rebecca Brown,
Pinelopi Manousou, Charles Millson, Mark Aldersley, Stuart Forbes,
Kosh Aggarwal, Amit Gera, Matthew Cramp, Andrew Holt,
David Mutimer, Stuart McPherson, Andrew Burroughs, Quentin Anstee,
Robert Goldin, Mark R. Thursz, The United Kingdom
LP12 SILYMARIN FOR THE TREATMENT OF NON-ALCOHOLIC
STEATOHEPATITIS: INTERIM ANALYSIS OF A
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED
TRIAL
Wah Kheong Chan*, Nik Raihan Nik Mustapha, Sanjiv Mahadeva,
Malaysia
LP13 EFFECT OF LONG TERM VIRAL SUPPRESSION WITH
SOFOSBUVIR + RIBAVIRIN ON HEPATIC VENOUS
PRESSURE GRADIENT IN HCV-INFECTED PATIENTS WITH
CIRRHOSIS AND PORTAL HYPERTENSION
Nezam Afdhal*, Gregory T. Everson, Jose Luis Calleja,
Geoffrey McCaughan, Jaime Bosch, Jill Denning, Diana M. Brainard,
John G. McHutchison, Theo Brandt-Sarif, Di An, Michael Charlton,
K. R. Reddy, Tarik Asselah, Edward Gane, Xavier Forns,
The United States
354 The International Liver Congress™ 2015 • ILC Programme
